10.2 CLINICALLY MEANINGFUL BIOMARKERS OF METABOLIC DYSFUNCTION DURING ANTIPSYCHOTIC TREATMENT IN CHILDREN AND ADOLESCENTS: THE ROLE OF ADIPOSITY AND LIVER FAT IN TREATMENT AND PREVENTION

Authors
Category Primary study
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Year 2021
This article has no abstract
Epistemonikos ID: d1f2ec522b6ed56937f2c4d36bd174ed22cbf21c
First added on: Feb 13, 2025